Jul 7, 2026Europe-US new drug manufacturing outsourcing gap grows | Bora completes MacroGenics buy

Jul 3, 2026Oligonucleotide CDMO market set to jump | WuXi Biologics sites get Brazil GMP certification

Jul 2, 2026Endress+Hauser opens new PA campus | AGC Biologics boosts US fill-finish via partnership

Jul 1, 20267 companies picked for FDA PreCheck pilot | Lonza adds payload-linker manufacturing capacity

Jun 30, 2026AI & vaccine manufacturing | 1st radiopharma manufacturing license under China’s new rules

Jun 27, 2026WuXi Biologics dodges bullet | Mammoth to advance gene-editing therapies in Abu Dhabi

Jun 26, 2026Chemical engineering & process development | GMP production at WuXi Biologics’ MFG17

Jun 25, 2026Lonza racks up ADC deals | Shilpa commissions ADC manufacturing facility in India

Jun 24, 2026China leads US in biomanufacturing | AdvanCell’s strategy to expand US footprint

Jun 23, 2026Lotte Biologics completes plant construction | Cellares vs. Ori Biotech in automation battle

Jun 19, 2026WuXi AppTec claims DoD caused it harm | Novo Nordisk begins production at Czech site

Jun 18, 2026AI finding role in pharma manufacturing | Catalent unveils AI quality management tool

Jun 17, 2026Lupin’s CDMO targets ADCs, peptides | Siegfried’s new German drug substance facility

Jun 16, 2026WuXi AppTec’s loss could be gain for India’s CRDMOs | Cellares grows Series D to $327M

Jun 13, 2026Is WuXi AppTec a Chinese military company? | Startup raises $23M for biomanufacturing platform

Jun 12, 2026Lilly uses AI to boost production | Axplora to consolidate manufacturing at India Site

Jun 11, 2026API, KSM sourcing leaves US vulnerable | Stevanato launches proprietary pen injector

Jun 10, 2026DoD puts WuXi AppTec on Chinese military list | Chime taps Cytiva to boost manufacturing

Jun 9, 2026June 8, 2026

Jun 6, 2026Pharma manufacturing to create 19,000 jobs through 2034 | Schott expands vial production in PA

Jun 5, 2026Lilly to halve $2.5B investment in new German site | Lonza boosts biologics preclinical development

Jun 4, 2026FDA aims to speed gene therapy development | SK bioscience becomes UNICEF flu vaccine supplier

Jun 3, 2026Will FDA’s PreCheck speed up US pharma buildouts? | Hikma’s $267M Ohio expansion

Jun 2, 2026Rise of biologics poses manufacturing challenges | VectorBuilder plans $50M biomanufacturing center

May 30, 2026Japanese pharma, peptides, and CDMOs | Recipharm boosts blow-fill-seal capacity

Latest Edition